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A B S T R A C T  
Background: Helicobacter pylori (H. pylori) have been associated with gastritis, but its presence in other parts of the gastrointestinal 
system has not been studied much. Few previous studies have identified “H. pylori” in gallbladder and found its association in 
causing cholecystitis and gallstones, but there is limited data showing a significant association in Pakistan. This study was designed 
to identify H. pylori microorganism in cholecystitis patients and find its association with the morphological changes seen in the 
affected gall bladders. 
Material and Methods: All patients with acute and chronic cholecystitis admitted in Akbar Niazi Teaching Hospital (ANTH) between 
the ages of 18 and 80 years from January 2017 till March 2019, who underwent cholecystectomy, were included in the study. Gall 
bladder specimens were sent to Pathology department, ANTH after surgery and were analyzed for the presence of H pylori bacteria 
using Hematoxylin and Eosin and Giemsa staining. Signs of inflammation, hyperplasia, metaplasia, mucosal atrophy or erosion, 
lymphoid infiltration, fibrosis, cholesterolosis or any other morphological changes were also noted. Association of H. pylori with 
cholecystitis and other morphological changes were assessed by Chi Square analysis. P value less than 0.05 was considered 
statistically significant. 
Results: Chronic cholecystitis was present in 91% cases and acute cholecystitis in 9%. Other histological findings were Hyperplasia 
(10%), Metaplasia (15%), Fibrosis (79%), Cholesterolosis (19%) and ulcerations (36%). H pylori was found in 17% of gall bladders 
and all the cases were of chronic cholecystitis, with 11.7% males and 88% females. Gallstones were present in 76.4% cases and 
were more common in 41-60 years’ age group (64.7%). Other histological findings seen in H. pylori positive cases were; Hyperplasia 
in 11.7% cases, Metaplasia in 17.6%, Fibrosis in 94.1%, cholesterolosis in 23.5% and ulcerations in 17.6% cases. Association of H. 
pylori with gender, cholecystitis, gall stones, histological features and age distribution was non-significant. 
Conclusion: Although H. pylori infection has been found in cases of chronic cholecystitis and gall stone formation, its association 
with cholecystitis and other morphological changes could not be proved. Hence, it is uncertain whether H. pylori eradication in 
patients with gastritis can prevent cholecystitis or gall stones formation. 
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I n t r o d u c t i o n  
 
Gallstone disease is the most commonly occurring 
disease in surgical practice with a prevalence of 10-15% 
in European population and 3-5% in Asian and African 
population.1 Internationally the reported prevalence of 
gallstone disease was 9.2% for Italy, 9.7 % for Spain, 
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28.5% for Chile and 3.1% for Thailand.2 In Pakistan, the 
incidence reported in previous years was 9.03%.2,3 
 
All over the world surgical units are managing many 
patients with gallstones every year and with 
cholecystectomy as one of the most common elective 
surgical procedure.1 In our setup in ANTH Bara Kahu, 
since last one-year (2017-2018), number of surgeries 
performed for gallstones have been at the top of the list 
i.e. 22% of all general surgical procedures (62 /286). 
Hyperlipidemia, sedentary lifestyle, low fiber, high fat diet, 
metabolic syndrome and diabetes are the commonest 
causative factors of gallstone formation leading to 
cholecystitis.4 
 
In recent years, few studies from Middle East5 and Asia 
(China,4,6,7, Iran,8,9, India10,11) have identified a new 
causative agent “H pylori” which plays a role in gall stone 
formation leading to cholecystitis. The initial study dates 
back to 1996 by Kawaguchi et al.12 who incidentally 
discovered a microorganism resembling H pylori from a 
cholecystectomy specimen. Since then many researches 
have been performed, but still this association has not 
been widely accepted due to the lack of proper evidence. 
Despite an overall percentage of approximately 20% 
being detected in gallbladder mucosa, according to 
various studies4, its eradication has not been practiced or 
proposed for cholecystitis. 
 
The prevalence of this bacteria is more in Asian 
population but only a few studies have been performed in 
Pakistan that have shown a significant association.3 
Therefore further studies are required, to elucidate the 
role of Helicobacter in hepatobiliary diseases in our setup. 
 
This gram-negative rod has previously been associated 
with gastritis and acid peptic disease8 for decades and 
studies have been carried out to show its association with 
gallstones, cholecystitis13,14 and gall bladder cancer.15 
Many serological and histological methods16,17 have been 
used to detect its presence in gall bladder mucosa and 
bile including Giemsa staining, H&E, PCR, Urease test, 
Warthin-starry18 test etc. Out of these Giemsa and H&E 
are considered the simplest, cheapest and most specific 
methods.2 Few studies have detected H. pylori in 
gallstones but that cannot establish its association with 
cholecystitis. Some of the studies conducted in 
Germany19, Brazil20 and Iran21 statistically show no 
significant association between H pylori and cholecystitis, 
but these studies were performed more than ten years 
back. 
 
Symptoms of acid peptic disease and cholecystitis are 
related and confusingly similar most of the time. In this 
cross-sectional study, we aimed to identify the association 
of H. pylori with cholecystitis ending up in 
cholecystectomy. If there is a significant evidence 
showing this relationship, this condition can be treated 
more conservatively. With the discovery of proton-pump 
inhibitors (PPIs) and triple therapy for H pylori infection, 
many gastric surgeries like Billroth I and II have become 
almost obsolete. Therefore, in the present study we 
looked for the presence of this microorganism in 
cholecystitis patients and its association with the 
morphological changes seen in gall bladders. 
 
M a t e r i a l  a n d  M e t h o d s  
This cross-sectional study was conducted by the 
Departments of Surgery and Pathology of Akbar Niazi 
Teaching Hospital (ANTH) Bara Kahu, Islamabad. Ethical 
approval was taken from Institutional Review Board of 
Islamabad Medical and Dental College. Sample collection 
was done using non probability convenience sampling. 
After taking informed consent, all patients with acute and 
chronic cholecystitis admitted in ANTH between the ages 
of 18 and 80 years from January 2017 till March 2019, 
who underwent cholecystectomy, were included in the 
study. Patients with Gall bladder tumors, hemolytic 
disease, patients who took triple regime antibiotic therapy 
for H. pylori eradication for gastritis were excluded from 
the study. 
 
Data was collected from a total of 100 patients by using 
HIMS (hospital information management system). It 
included patient’s demographics i.e. age, gender, weight, 
residence and clinical data including; presenting 
complains, associated gastritis, comorbidity like diabetes, 
Total leukocyte court (TLC), Liver function tests (LFTs). 
Ultrasonographic findings of presence or absence of gall 
stones, gall bladder wall inflammation (edematous or wall 
thickness) and presence of pericholecystic fluid were also 
noted. 
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 Gall bladder specimens were sent to Pathology 
department, ANTH after surgery and specimens were 
analyzed for the presence of H pylori bacteria using H&E 
and Giemsa staining22. Signs of inflammation, 
hyperplasia, metaplasia, mucosal atrophy or erosion, 
lymphoid infiltration, fibrosis, cholesterolosis or any other 
morphological changes were noted. Result of categorical 
variables were presented as frequency and percentages. 
Continuous variables were expressed as mean and 
standard deviation. Association of H.pylori with 
cholecystitis, morphological changes and other variables 
was checked by Chi Square test. P ≤ 0.05 was 
considered statistically significant.  Patients identity was 
not disclosed. 
 
R e s u l t s  
A total of 100 patients underwent cholecystectomy. 
According to age, most of the patients (n=52) were in 41-
60 years’ age group, followed by 20-40 years (n=38), and 
61-80 years age group (n=10). Female predominance 
was observed with 88% females (n=88) and 12% males 
(n=12). All the patients had symptoms of upper abdominal 
pain and dyspepsia. Chronic cholecystitis was the most 
common presenting feature (91%) followed by gall stones 
(75%) and a few cases of acute cholecystitis (9%). Other 
histological findings were Hyperplasia (10%), Metaplasia 
(15%), Fibrosis (79%), Cholesterolosis (19%) and 
Ulcerations (36%). Histological appearance of 
Cholesterolosis is shown in Figure 1. H. pylori was seen 
in mucosa of gall bladders of 17 patients (17%) (Figure 2). 
 
Among those patients, male/female ratio was 1:7.5. Most 
of the patients were in the 41-60 years’ age group. 
Chronic cholecystitis was present in all cases followed by 
gall stones. Fibrosis was the most common histological 
feature. Association of H-Pylori with gender, cholecystitis, 
gall stones, histological features and age distribution was 
non-significant (Table I). 
 
 
Figure 1: Section showing cholesterolosis (Lipid laden 
histiocytes) in lamina propria of gallbladder (H&E X 100) 
Table I: Association of H-Pylori with study variables 
 Features H pylori +ve 
n (%) 
H pylori –ve 
n (%) 
P-value 
 Gender  
0.97 1 Males 2(11.7) 10(83) 
2 Females 15(88) 73(82) 
 Diagnosis  
 
0.56 1 Chronic  
cholecystitis 
17(100) 83(91) 
2 Acute  
cholecystitis 
0(0) 9(100) 
 Presence of Gallstones  
1 Gall stones 13(76.4) 62(82) 0.87 
2 No gallstones 4(23.5) 21(84) 
 Histological Features  
 
 
0.59 
1 Hyperplasia 2(11.7) 8(80) 
2 Metaplasia 3(17.6) 12(80) 
3 Fibrosis 16(94.1) 63(79.7) 
4 Cholesterolosis 4(23.5) 15(98.9) 
5 Erosions/ 
Ulcerations 
3(17.6) 33(91.6) 
 Age Distribution (years)  
 
0.59 
1    
2    
3 
20-40 
41-60 
61-80 
6(35.3) 
11(64.7) 
0(0) 
32(84.2) 
41(78.8) 
10(100) 
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Figure 2: Histological section from gallbladder showing H. 
pylori in the mucosa (Giemsa stain X 400). 
 
 
D i s c u s s i o n  
H pylori has been mostly associated with gastritis but its 
presence in other parts of gastrointestinal system has not 
been studied much. It was first detected in gall bladder by 
Kawaguchi in 1996, which opened the door to further 
research.12 The epithelial cells of human gallbladder can 
be damaged by H. pylori leading to Cholecystitis. A meta-
analysis of previous researches show association 
between gallbladder diseases and Helicobacter infection.3 
It is also believed that chronic inflammation is an 
underlying cause of development and progression to 
cancers. Previous research has also shown that 
Helicobacters release metabolites and several toxins that 
are carcinogenic.23 
So far, no definite association has been established 
between H. pylori infection and cholecystitis. Also, there is 
no evidence of the exact pathway by which H. pylori 
bacteria reaches the hepatobiliary system.4 
 
Risk factor such as age and gender play an important role 
in formation of gall stones but their role in chronic 
cholecystitis is still not clear. According to a study by Bohr 
et al, all female patients above 65 years of age had an 
association with gallstone formation. Another study by 
Bulajic, et al showed association of H. pylori infection in 
bile with age but no association was seen with gender. In 
that study, more frequency of H. pylori infection was 
present in patients above 70 years of age.4 
 
Our study showed presence of H. pylori in 17% of the gall 
bladder specimens with majority being females (88%) with 
gallstones (76.4%) and all of them having chronic 
cholecystitis.  The most commonly involved age group 
was 41-60 years (64.7%). Two studies conducted in 
Pakistan (Abro et al3 and Yakoob et al13) reported 
presence of H. pylori in 55% and 25% patients 
respectively which is much higher than our patients 
(17%).  
 
All the patients in our study had symptoms of upper 
abdominal pain and dyspepsia and no difference was 
found in both the groups. In all H pylori positive cases, 
chronic cholecystitis was present (100%), although a 
significant percentage of H pylori negative cases (91%) 
also showed chronic inflammation. 
 
Some of the studies have also shown an association of H 
pylori infection in gall bladders with gall bladder cancer. In 
a study by Bulajic et al, H. pylori was found 9.9 times 
more frequently in cases of gallbladder carcinoma when 
compared with normal controls and it was found 3.5 times 
more frequently in cases with gallstones.24 In another 
study, presence of Helicobacter pylori and Helicobacter 
bilis was confirmed in bile as well as gallbladder of 
patients having gallbladder carcinoma and chronic 
cholecystitis. It was observed that H. pylori was present in 
more than 75 % of patients with gallbladder cancer and it 
was present in more than 50 % of patients having chronic 
cholecystitis.25 In our study, we did not find any such 
evidence but metaplasia was noted in 17.6 % of the 
patients with H pylori infection and in 88% patients without 
H pylori infection. In a study by Hassan et al, metaplasia 
was found in 28% of the patients with H pylori infection 
and only 4% in patients without H pylori infection. 
Therefore, in their study there was a statistically 
significant difference between the two groups (P=0.049) 
regarding mucosal metaplasia.16 
 
Regarding association of H. pylori infection with gall 
stones, it was more common in H. pylori negative cases 
(82%) as compared to H pylori positive cases (76%). The 
results were similar to that of another study in which the 
prevalence of gallstones in H pylori positive cases was 
lower than in the H pylori-negative cases (odds ratio, 
0.653)11 
 
In our study, fibrosis was present in most of the H pylori 
positive cases (94%) whereas it was less (79%) in non-
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infected patients proving its association with chronic 
cholecystitis. In another study, 36% cases of H pylori 
positive group had fibrosis but the same frequency was 
also seen in H pylori negative group and therefore no 
statistically significant difference was noted regarding 
fibrosis between both the groups16 
 
When analyzed statistically, comparison of patients with H 
pylori positive and H pylori negative was not found 
significant in any of the findings. In another study, 
regarding gender, mean age, type of inflammation and 
stone formation, no statistically significant difference was 
noted between the two groups of H pylori positive and 
negative cases.16 Similarly in another study, similar 
results were found.26 
 
It is still not known how these bacteria find their way into 
the gall bladder, but most probable theory is that it travels 
from stomach to duodenum and through sphincter of Odi 
enters the biliary system and resides in gall bladder. 
 
C o n c l u s i o n  
H pylori infection has been found in cases of chronic 
cholecystitis and cholelithiasis, its association with 
cholecystitis and other morphological changes could not 
be proved. Hence, it is uncertain whether H pylori 
eradication in patients with gastritis can prevent 
cholecystitis or gall stones formation. Further studies are 
required with higher number of patients and different 
histological methods to prove this association. 
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